Brief report: inhaled corticosteroid use and the risk of checkpoint inhibitor pneumonitis in patients with advanced cancer

BACKGROUND: Checkpoint inhibitor pneumonitis (CIP) is an immune-related adverse event that may complicate treatment with immune checkpoint inhibitors (ICI) and can cause significant morbidity. We sought to identify predictors for the development of CIP, and whether the use of inhaled corticosteroids...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Immunol Immunother
Main Authors: Li, Mingjia, Spakowicz, Daniel, Zhao, Songzhu, Patel, Sandip H., Johns, Andrew, Grogan, Madison, Miah, Abdul, Husain, Marium, He, Kai, Bertino, Erin M., Shields, Peter G., Wei, Lai, Carbone, David P., Otterson, Gregory A., Presley, Carolyn J., Owen, Dwight H.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Berlin Heidelberg 2020
Assuntos:
Research Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7572636/
https://ncbi.nlm.nih.gov/pubmed/32728772
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-020-02674-w
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados